What happened
GemVax & Kael disclosed an acquisition of Korea Stem Cell Bank Co., Ltd., worth US$8.42M.
For context, this deal is worth about 7.8% of the company's own total assets.
| Target | Korea Stem Cell Bank Co., Ltd. |
|---|---|
| Deal value | US$8.42M |
| vs. company assets | 7.8% |
| Filed | 2026-04-28, Decision to acquire shares/equity in another company |
| Source | DART rcept 20260428901035 → open original filing |
Source: DART. Information only, not investment advice.